logo

CN | EN
4
3
2
1

The company is a high-tech private enterprise mainly engaged in the research and development, manufacturing and sales of biological engineering..

Wuhan zhongyou pharmaceutical co., ltd. has made a series of breakthroughs in the field of liver disease, digestive tract and other major diseases

Zhongyou pharmaceutical co., LTD has established cooperative relationship with many world-class enterprises and r&d institutions

Take corporate culture as the source. Build a good image, show the elegant demeanor of employees, enhance internal communication...

NEWS

11-22

Development of lipid-lowering drugs continue to hot regulatory approval to shift to the end of the disease

The recent development of lipid-lowering drugs is very popular. A new lipid-lowering drug ETC-1002 from Esperion Therapeutics not only outperformed Merck's Zetia (generic name: Ezetimibe) in a mid-ter
11-22

Development of lipid-lowering drugs continue to hot regulatory approval to shift to the end of the disease

The recent development of lipid-lowering drugs is very popular. A new lipid-lowering drug ETC-1002 from Esperion Therapeutics not only outperformed Merck's Zetia (generic name: Ezetimibe) in a mid-ter
11-22

A breakthrough in stem cell research progresses in the cure or re-emergence of diabetes

DouglasMelton,adevelopmentalbiologistattheStemCellResearchInstituteatHarvardUniversity,andcolleaguesrecentlyreportedanewtechniqueinthejournalCelltosuccessfullytransformhumanembryonicstemcells(ESC)orin
Previous page
1
2
TCX

WeChat

TCX

Mobile web site

Contact us

Tel:0711-5920666
Fax:0711-5920600

E-mail:business@zypharma.net

Add:28 chuangye avenue, gedian development zone

Copyright©2019 Wuhan ZhongYou Pharmaceutical Co., Ltd.

 鄂ICP备12014712号      Design  By 300.cn